Are estradiol (E2) levels of 183 pg/mL, progesterone (P4) levels of 7.17 ng/mL, and dehydroepiandrosterone (DHEA) levels of 160.3 mcg/dL within normal ranges for a 39-year-old female?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Interpretation of Hormone Levels in a 39-Year-Old Female

The hormone levels of estradiol 183 pg/mL, progesterone 7.17 ng/mL, and DHEA 160.3 mcg/dL are within normal ranges for a 39-year-old female, suggesting normal ovarian function consistent with the luteal phase of the menstrual cycle.

Normal Hormone Ranges and Interpretation

Estradiol (E2)

  • Estradiol level of 183 pg/mL falls within the expected range for the luteal phase of the menstrual cycle in a premenopausal woman 1
  • This level is significantly higher than postmenopausal values, which would typically be much lower (<30 pg/mL) 2
  • The measurement is consistent with normal ovarian function for a 39-year-old woman 1

Progesterone (P4)

  • Progesterone level of 7.17 ng/mL indicates luteal phase levels, suggesting recent ovulation 1
  • Mid-luteal phase progesterone typically ranges from 5-20 ng/mL, placing this value within normal parameters 1
  • This level is significantly higher than follicular phase or postmenopausal values, which would typically be <1 ng/mL 3

DHEA

  • DHEA level of 160.3 mcg/dL is within normal range for a woman of this age 4
  • DHEA is primarily produced by the adrenal glands and serves as a precursor for other sex hormones 4
  • Normal DHEA levels suggest proper adrenal function 5

Hormonal Patterns and Menstrual Cycle

  • The combination of moderately elevated estradiol and progesterone >5 ng/mL strongly suggests the woman is in the luteal phase of her menstrual cycle 1
  • These values represent a snapshot of a dynamic hormonal system that fluctuates throughout the menstrual cycle 1
  • Day-specific sampling can significantly affect hormone measurements - progesterone peaks between days 17-21 of the cycle 1

Laboratory Considerations

  • Hormone measurements have inherent variability - coefficients of variation for estradiol can range from 10-20% in premenopausal women 6
  • Single measurements should be interpreted with caution, as they represent only one point in a fluctuating hormonal pattern 6
  • Laboratory reproducibility for progesterone measurements in cycling women is generally reliable with intraclass correlation exceeding 90% 6

Clinical Implications

  • These normal hormone levels suggest:

    • Intact hypothalamic-pituitary-ovarian axis 5
    • Normal ovulatory function 1
    • Absence of premature ovarian insufficiency, which would present with low estradiol and high FSH 5
    • No evidence of adrenal dysfunction based on normal DHEA levels 5
  • At age 39, monitoring ovarian reserve may be considered if fertility is a concern, though these specific hormone measurements don't directly assess ovarian reserve 5

Conclusion

The hormone profile with estradiol of 183 pg/mL, progesterone of 7.17 ng/mL, and DHEA of 160.3 mcg/dL represents normal values for a 39-year-old female, most consistent with luteal phase of the menstrual cycle. No further hormonal evaluation is necessary based on these results alone.

References

Research

The optimal timing of blood collection during the menstrual cycle for the assessment of endogenous sex hormones: can interindividual differences in levels over the whole cycle be assessed on a single day?

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2002

Research

Laboratory reproducibility of endogenous hormone levels in postmenopausal women.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 1994

Research

Treatment of moderate to severe dyspareunia with intravaginal prasterone therapy: a review.

Climacteric : the journal of the International Menopause Society, 2019

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Reproducibility studies and interlaboratory concordance for assays of serum hormone levels: estrone, estradiol, estrone sulfate, and progesterone.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.